Tempus AI Inc.
Tempus AI Announces Strategic Partnership for Oncology Model Development
Summary
On April 17, 2025, Tempus AI, Inc. entered into agreements with AstraZeneca AB and Pathos AI, Inc. for the development of a foundational large multimodal model in oncology and the licensing of de-identified multi-modal data. AstraZeneca will pay Tempus $35 million, and Pathos will pay Tempus $200 million over three years for data licensing. Tempus will receive a license to use the Foundational Model upon its completion and will pay Pathos $35 million. Pathos may pay up to 50% of the data license fees in shares of its Series D Preferred Stock.
Profitelligence Alerts
Get alerts for TEM
Be first to know when Tempus AI Inc. files with the SEC.
Filing Categories
Advertisement
About Tempus AI Inc.
Tempus AI Inc. is a pioneering technology company specializing in the development and application of artificial intelligence solutions across various industries. Its primary function is to harness AI-driven insights to enhance operational efficiency and decision-making processes for enterprises. Tempus AI Inc. is at the forefront of integrating machine learning into sectors such as healthcare, finance, and logistics, where predictive data analytics can provide substantial competitive advantages. The company delivers bespoke AI platforms that enable organizations to streamline complex data sets into actionable intelligence. Its expertise extends to natural language processing and computer vision, offering comprehensive AI tools that drive innovation and efficiency. As a significant player in the tech market, Tempus AI Inc. contributes to setting industry standards for AI deployment, impacting how businesses leverage intelligent technology to improve outcomes and strategic planning. Founded with a mission to propel the development of intelligent systems, Tempus AI Inc. remains a vital contributor to the digital transformation of multiple industries, facilitating the transition towards a more data-driven future.
Official SEC Documents
Advertisement